NEXPOINT ASSET MANAGEMENT, L.P. Q3 2020 Filing
Filed November 16, 2020
Portfolio Value
$442.0M
Holdings
156
Report Date
Q3 2020
Filing Type
13F-HR
All Holdings (156 positions)
| Stock | Value |
|---|---|
ZBHZIMMER BIOMET HOLDINGS INC | $545K |
CIOCITY OFFICE REIT INC | $532K |
CNCCENTENE CORP DEL | $525K |
—GORES HLDGS V INC | $518K |
—GO ACQUISITION CORP | $491K |
—TWC TECH HLDGS II CORP | $485K |
AMTAMERICAN TOWER CORP NEW | $483K |
LINLINDE PLC | $476K |
AALAMERICAN AIRLS GROUP INC | $474K |
BDXBECTON DICKINSON & CO | $465K |
ILMNILLUMINA INC | $464K |
—THUNDER BRDG ACQUISTION II L | $449K |
PDCOEURPATTERSON COS INC | $415K |
—VESPER HEALTHCARE ACQSTN COR | $410K |
—MOBILEIRON INC | $397K |
PRCPGBPPERCEPTRON INC | $394K |
—INNERWORKINGS INC | $393K |
—BIOHAVEN PHARMACTL HLDG CO L | $390K |
CBNABRIDGE BANCORP INC | $388K |
IM8NINSMED INC | $386K |
—MONTAGE RES CORP | $383K |
DVNDEVON ENERGY CORP NEW | $383K |
BMRNBIOMARIN PHARMACEUTICAL INC | $380K |
—BITAUTO HLDGS LTD | $347K |
SUPVGRUPO SUPERVIELLE S.A. | $342K |
SGRYSURGERY PARTNERS INC | $341K |
LOMALOMA NEGRA CORP | $332K |
PAGPPLAINS GP HLDGS L P | $324K |
—GS ACQUISITION HLDGS CORP II | $298K |
—HEALTHCARE MERGER CORP | $296K |
—CIIG MERGER CORP | $292K |
MRNAMODERNA INC | $283K |
MBIOUSDMUSTANG BIO INC | $268K |
STNESTONECO LTD | $264K |
—HUDSON EXECUTIVE INVT CORP | $246K |
KKRKKR & CO INC | $241K |
ESTAESTABLISHMENT LABS HLDGS INC | $222K |
SRCUSDSPIRIT RLTY CAP INC NEW | $221K |
EBIXEUREBIX INC | $214K |
—COHN ROBBINS HOLDINGS CORP | $202K |
NERVGBPMINERVA NEUROSCIENCES INC | $201K |
—HIGHCAPE CAP ACQUISITION COR | $194K |
LXFRLUXFER HOLDINGS PLC | $187K |
GNWGENWORTH FINL INC | $170K |
NKTREURNEKTAR THERAPEUTICS | $166K |
B7SBROOKDALE SR LIVING INC | $157K |
—FTAC OLYMPUS ACQUISITION COR | $134K |
—CF FINANCE ACQUISITION CORP | $134K |
—FORTRESS VALUE ACQUISITION I | $129K |
ITUBITAU UNIBANCO HLDG S A | $126K |
—AGILE THERAPEUTICS INC | $76K |
—VYNE THERAPEUTICS INC | $67K |
EOLSEVOLUS INC | $39K |
9KGNEXTIER OILFIELD SOLUTIONS | $35K |
—CHURCHILL CAPITAL CORP IV | $30K |
—EYEPOINT PHARMACEUTICALS INC | $18K |
PreviousPage 2 of 2